Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practice.

Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practice. Clin Drug Investig. 2012 Aug 08; 32 Suppl 2:1-2.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.